Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Morning Market Movers

Courtesy of Benzinga.

Related MOVE
Benzinga's Top #PreMarket Gainers
US Stock Futures Surge Ahead Of Walgreen Earnings, Economic Data

Related NWSA
Carl Icahn Discloses Stake in Gannett, Supports the Split
5 Recent Big Media Spinoffs
What the Tribune Split Means for the Newspaper Biz (Fox Business)

Move (NASDAQ: MOVE) shares jumped 36.89% to $20.93 after the company agreed to be acquired by News Corp (NASDAQ: NWSA) for $21 per share, or $950 million.

ChinaNet Online Holdings (NASDAQ: CNET) climbed 18.44% to $3.79 as Liansuo subsidiary signed 12 new clients.

Catalyst Pharmaceutical Partners (NASDAQ: CPRX) shares climbed 13.71% to $3.40 after the company reported positive top-line Phase 3 data from pivotal Firdapse clinical trial.

Teekay (NYSE: TK) shares gained 12.98% to $65.94 after the company announced its plans to increase dividend by 75%-80%.

Vimicro International (NASDAQ: VIMC) shares increased 12.39% to $10.27 after the company announced a $12.4 million contract win in Taiyuan City of Shanxi Province. The company’s joint venture, Shanxi Zhongtianxin Science and Technology Co, secured a $65 million revolving line of credit.

eBay (NASDAQ: EBAY) shares gained 7.35% to $56.53 after the company announced its plans to separate eBay and PayPal into two publicly traded companies in 2015.

SYNNEX (NYSE: SNX) gained 7.16% to $66.64 after the company reported stronger-than-expected Q3 earnings and announced the initiation of $0.125 per share quarterly dividend.

JAKKS Pacific (NASDAQ: JAKK) gained 5.22% to $7.25 after rising 2.38% on Monday.

Ceragon Networks (NASDAQ: CRNT) shares rose 4.93% to $2.34 after the company reported that it has received follow-on orders from a global Tier 1 operator serving 20 countries across Asia and Africa.

Ballard Power Systems (NASDAQ: BLDP) shares rose 3.14% to $3.28 after the company reported that it has received a ElectraGen fuel cell system order for deployments in Digicel network.

Walgreen Co (NYSE: WAG) climbed 2.06% to $60.83 after the company reported in-line profit for the fourth quarter.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

#PreMarket Primer: Tuesday, September 30: Hong Kong Protests Continue Despite Efforts To Disperse

Courtesy of Benzinga.

Related SNX
Stocks To Watch For September 30, 2014
Benzinga Weekly Preview: Geopolitical Tension, Economic Data To Drive Markets
Related CTS
#PreMarket Primer: Monday, September 29: Protesters Vow To Continue Fighting For Democracy In Hong Kong
TE Connectivity to Buy Measurement Specialties – Analyst Blog

Protesters in Hong Kong extended the blockade on Tuesday and prepared for the return of riot police as Chinese National Day approached.

Over the weekend, police attempted to clear the protesters using pepper spray and tear gas before withdrawing on Monday.

The government asked protesters to disperse peacefully, but instead the tens of thousands of people began to stockpile supplies and create more barricades, indicating that their fight for full democracy was far from over.

Top News

In news around the markets:

Data Show Increased U.S. Spending

Consumer spending data out on Monday suggested that the U.S. economy is set to grow steadily in the third quarter. The report showed that U.S. household spending increased by 0.5 percent from July to August, and that spending was up 4.1 percent from last year’s figures. The figures fall in line with most economists expectations for solid U.S. GDP growth in the third quarter.

Ukrainian Ceasefire Under Pressure

The ceasefire in Ukraine faced more challenges after the Ukrainian military announced that separatist rebels’ fire in Donetsk killed seven soldiers. The fighting took place near the Donetsk airport, the only part of the city still held by nationalist forces, and served as a reminder that the Ukrainian conflict is not yet over.

Albertsons Supermarkets Suffer From Data Breach

AB Acquisition LLC announced that customer data from some of its Albertsons supermarkets may have been compromised due to a hacking incident. Now, investigators are looking into the issues for more detail about the depth of the attack, but the incident is believed to have taken place between late…
continue reading

UPDATE: Credit Suisse Reiterates On Frank's International NV On Revised Valuation Parameters

Courtesy of Benzinga.

Related FI
Benzinga's Top Initiations
Jefferies Initiates Frank's International With Hold

In a report published Tuesday, Credit Suisse analyst James Wicklund reiterated a Neutral rating on Frank’s International NV (NYSE: FI), but lowered the price target from $24.00 to $22.00.

In the report, Credit Suisse noted, “This piece is intended to clarify the valuation of Frank’s to take into account the minority interest ownership of the family private partnership. While it has no impact on the P/E valuation, it does impact the EV/EBITDA valuation – the primary metric typically used in the OFS sector.”

Frank’s International NV closed on Monday at $19.28.

Latest Ratings for FI

Date Firm Action From To
Sep 2014 KeyBanc Initiates Coverage on Buy
Sep 2014 FBR Capital Maintains Outperform
Aug 2014 Goldman Sachs Upgrades Sell Neutral

View More Analyst Ratings for FI
View the Latest Analyst Ratings

Posted-In: Credit Suisse James WicklundAnalyst Color Price Target Analyst Ratings

Amedica Corporation Appoints Dr. B. Sonny Bal New President And CEO

Courtesy of Benzinga.

Related AMDA
Amedica Secures $26 Million In Funding

Amedica Corporation (Nasdaq: AMDA), a commercial biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range of medical devices, is pleased to announce its Board of Directors has elected B. Sonny Bal, MD, JD, MBA, to serve as its President and Chief Executive Officer effective September 30, 2014. Dr. Bal has served as a member of Amedica’s Board of Directors since February 2012, and as its Chairman since August 20, 2014. Dr. Bal succeeds Eric K. Olson as President and Chief Executive Officer of Amedica effective September 30, 2014.

“Dr. Bal brings a truly unique set of skills and leadership abilities to Amedica at this important time in its history,” said Jeff White, a member of Amedica’s Board of Directors. “He is a skilled and thought-leading clinician as well as a professor of orthopaedic surgery, a licensed attorney, and a Kellogg MBA. The Company is truly fortunate to benefit from Dr. Bal’s unique clinical, business and leadership skills. Dr. Bal’s many years of clinical and scientific commitment to ceramics in orthopaedics and spine will make him an effective champion and leader for Amedica.”

Dr. Bal is Professor of Orthopaedic Surgery at the University of Missouri, Columbia, specializing in joint replacement surgery. His research interests include ceramic materials in orthopaedic surgery, and bioactive glasses. He also serves as Adjunct Professor of Material Sciences at the Missouri Science and Technology University, at Rolla, Missouri. Dr. Bal is a member of the American Academy of Orthopaedic Surgeons, the American Association of Hip and Knee Surgeons, and the Association of Bone and Joint Surgeons. He is a life member of the International Society of Technology in Arthroplasty, and serves on the editorial board of several peer-refereed orthopaedic journals. He has published extensively on the biomedical applications of silicon nitride ceramics, and continues that work, with presentations at scientific forums worldwide.

In addition to guiding Amedica on the commercialization of silicon nitride ceramic, Dr. Bal also leads the company’s Adult Reconstructive and Spine Medical Advisory Boards.

Dr. Bal received his MD degree from Cornell University; MBA degree from Kellogg Business School…
continue reading

Online Real Estate Listers Roiled By Rupert Murdoch's News Corp Move

Courtesy of Benzinga.

Related NWS
Gannett Co. Spikes; Icahn Discloses 6.63% Stake
Carl Icahn 13F Filing Shows $229M Stake In Gannett

A group of online real estate listing services got roiled in Tuesday's market with news that media maven Rupert Murdoch wants a piece of the sector.

The 83-year-old Murdoch's News Corp. (NASDAQ: NWS) said Tuesday it will pay $950 million, or $21 per share, to buy an 80 percent stake in Move Inc. (NASDAQ: MOVE), which operates listing sites that include and

Zillow Inc (NASDAQ: Z), which unveiled a plan in July to acquire rival Trulia Inc (NYSE: TRLA) for $3.5 billion, saw its shares tumble nearly 4 percent Tuesday in the wake of Murdoch's announcement.

Trulia shares sank nearly 3 percent, while Move gained 37 percent to $20.97 per share.

Antitrust regulators earlier this month requested more information about Zillow's proposed deal, although it's still expected to close next year.

Together, Zillow and Trulia would claim 137 million users, while Move now claims about 37 million users. Other estimates suggest 95 million users for a combined Zillow and Truglia — and 25 million for Move.

Zillow had revenue of $78.7 million and Trulia had revenue of $64.1 million while Move posted $61.3 million in revenue.

Other competitors in the online space include Classified Ventures LLC, Craigslist, Dominion Enterprises , Google Inc., Redfin, LLC, ZipRealty Inc.

Posted-In: Rupert MurdochNews M&A Intraday Update

10 Investor Questions About The eBay Inc-PayPal Split

Courtesy of Benzinga.

Related EBAY
Experts, Investors Applaud eBay Inc-PayPal Split
Keefe, Bruyette & Woods Is Not Entirely Surprised By eBay Inc Separation Announcement
The Mobile Messaging War: And the Winner is … (Fox Business)

News of the eBay Inc (NASDAQ: EBAY) PayPal split is hitting the market this Tuesday morning. Some analysts have already theorized about the scenario.

Back in March, Robert S. Peck, Managing Director and Internet Equity Analyst at SunTrust Robinson Humphrey (STRH), explained his take.

In a research note titled "Should eBay Spin PayPal?," Peck discussed the top 10 questions he’d heard from investors on the subject. Excerpts from his analysis are quoted below; the emphasis is in Peck’s original.

Related Link: eBay Inc – PayPal Split: What The Market Thinks

Can you quantify what the difference can be in total asset value with a spin vs. the status quo?

STRH: We think the onus here is on Mr. Icahn’s team to provide a detailed breakout of potential asset values, post a spin. There are likely both revenue synergies and incremental costs to gauge, coupled with various valuation multiple scenarios relative to comps. We provide some of our scenarios below.

What exactly is the data that is shared between PayPal and eBay, and why couldn’t that be done contractually if there was a spin?

STRH: We believe there is valuable data shared between PayPal and eBay, particularly on the risk modelling side with regards to sellers. However, we would like more clarity on what that data is exactly and whether it could be shared through a contractual agreement.

What Are the Current Revenue Opportunity Costs for Both, if any?

STRH: Are there situations where PayPal loses out on business because of its affiliation with eBay (i.e., or Amazon)? We think there could be, but any clarification would be helpful.

Further, could Marketplaces miss out on any opportunities by not permitting any other payment networks example…
continue reading

UPDATE: Stifel Initiates Coverage On Atlas Resource Partners, L.P. On Positive Outlook

Courtesy of Benzinga.

Related ARP
Atlas Resource Partners To Enter Eagle Ford Shale Through Acquisition Of Oil Rich Production And Undeveloped Locations
Atlas Resource Partners, L.P. Increases Monthly Distribution To $0.1966 For June 2014

In a report published Monday, Stifel analyst Brian Brungardt Jr. initiated coverage on Atlas Resource Partners, L.P. (NYSE: ARP) with a Buy rating and $22.00 price target.

In the report, Stifel noted, “We are initiating coverage of Atlas Resource Partners LP (ARP) with a Buy rating and a $22 target price. With the recent acquisition of Eagle Ford assets and secured financing, we believe unitholders stand to benefit from a growing organic project backlog and diversified geographic footprint. By funding the acquisition through a mix of newly issued Class D preferreds and use of its credit revolver, we believe unitholders stand to benefit from an improving DPU coverage ratio in 4Q14 and into FY15.”

Atlas Resource Partners, L.P. closed on Friday at $19.08.

Latest Ratings for ARP

Date Firm Action From To
Sep 2014 Stifel Nicolaus Initiates Coverage on Buy
May 2014 JP Morgan Maintains Neutral
May 2014 Bank of America Reinstates Neutral

View More Analyst Ratings for ARP
View the Latest Analyst Ratings

Posted-In: Brian Brungardt Jr. StifelAnalyst Color Initiation Analyst Ratings

Stifel Nicolaus Initiates LRR Energy At Buy

Courtesy of Benzinga.

Related LRE
Why LRR Energy (LRE) Stock Might be a Great Pick – Tale of the Tape
Earnings Scheduled For March 5, 2014

Analysts at Stifel Nicolaus initiated coverage on LRR Energy, L.P. (NYSE: LRE) with a Buy rating.

The target price for LRR Energy is set to $18.50.

LRR Energy shares have jumped 11.05% over the past 52 weeks, while the S&P 500 index has gained 17.21% in the same period.

LRR Energy’s shares rose 1.73% to close at $17.69 on Friday.

Latest Ratings for LRE

Date Firm Action From To
Sep 2014 Stifel Nicolaus Initiates Coverage on Buy
Aug 2014 Wells Fargo Upgrades Market Perform Outperform
Aug 2014 Wells Fargo Downgrades Outperform Market Perform

View More Analyst Ratings for LRE
View the Latest Analyst Ratings

Posted-In: Stifel NicolausInitiation Analyst Ratings

FBN Securities Thinks GoPro Inc Has More Room To Go

Courtesy of Benzinga.

In a note Monday morning, FBN Securities analyst Shebly Seyrafi maintained his Outperform rating and upped his price target on shares of GoPro Inc (NASDAQ: GPRO) from $70 to $90. This follows the announcement Monday of the new HERO4 and entry level HERO capture devices by GoPro.

Seyrafi feels the company's introduction of the entry-level HERO at a $129 MSRP will allow HERO to better sell into the mass market, while also allowing for upgrade opportunities over time. He also expects strong sales of the new HERO4 Black, with the higher end models accounting for the majority of the revenues.

Seyrafi had initiated coverage oon September 8. Since then, shares of rose 30.4 percent, moving from $58.75 to $89.15.

Shares of GoPro traded recently at $87.09, up 6 percent on the day.

Latest Ratings for GPRO

Date Firm Action From To
Sep 2014 FBN Securities Maintains Outperform
Sep 2014 Piper Jaffray Maintains Overweight
Sep 2014 JP Morgan Maintains Neutral

View More Analyst Ratings for GPRO
View the Latest Analyst Ratings

Posted-In: FBN Securities Shebly SeyrafiNews Price Target Reiteration Analyst Ratings

Micron Technology, Inc. Benefits From Industry Consolidation, Analysts Say

Courtesy of Benzinga.

Related MU
Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26
Stocks Record Weakest Week In Month Despite Friday Rally
Good Time to Buy Micron Technology, Cummins? (Fox Business)

Micron Technology, Inc. (NASDAQ: MU) may be gaining stability from and industry consolidation among computer chip makers, an analyst said Friday.

Micron shares rose sharply after missing fiscal first-quarter Street views but forecasting sales of its dynamic random-access memory chips well above expectations.

“Limited industry supply growth is driving less price volatility,” Deutsche Bank’s Sidney Ho said in a note reiterating a Buy rating and $40 target.

Related Link: What Do ‘The Secret Goldman Sachs Tapes’ Say?

The company forecast that sales growth for its DRAM chips will increase in the “low single-digits,” well above the decline of 5 percent to 10 percent many analysts expected.

Profit margins for the segment ticked up slightly and Ho sees room for further widening.

“Bears have consistently worried about falling DRAM prices,” Jefferies’ Sundeep Bajikar said in a note. But Bajikar sees a “permanent change” in the industry stemming from consolidation as well as slowing technological progress.

Pacific Crest’s Monika Garg cautioned, however, that that margins for the segment “could be at risk” with prospects for expanded manufacturing capacity at competitors Samsung and Hynix.

Garg reiterated a Sector Perform rating and noted that capital spending budgets among Micron’s competitors are double the size seen in a 2012 trough.

Latest Ratings for MU

Date Firm Action From To
Sep 2014 Stifel Nicolaus Maintains Buy
Jun 2014 Macquarie Maintains Neutral
Jun 2014 Needham Upgrades Buy Strong Buy

View More Analyst Ratings for MU
View the Latest Analyst Ratings

Posted-In: Deutsche Bank Jefferie Monika Garg Pacific CrestAnalyst Color Price Target Reiteration Analyst Ratings Best of Benzinga


Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

Thank you for you time!


Zero Hedge

RX For Revisionist Bunkum: A Lehman Bailout Wouldn't Have Saved The Economy

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Submitted by David Stockman via Contra Corner blog,

Here come the revisionists with new malarkey about the 2008 financial crisis. No less august a forum than the New York Times today carries a front page piece by journeyman financial reporter James Stewart suggesting that Lehman Brothers was solvent; could and should have been bailed out; and that the entire trauma of the financial crisis and Great Recession might have been avoided or substantially mitigated:

What happened that September was the culmination o...

more from Tyler

Phil's Favorites

Yeah I said it.

Yeah I said it.

Courtesy of 

Flowchart: Is my stock going up?

— Downtown Josh Brown (@ReformedBroker) September 30, 2014


Yes, this is basically what the “rally” has come to. Change is due in one direction or the other, the present condition is unsustainable.



more from Ilene

Chart School

Moving Averages: Month-End Update

Courtesy of Doug Short.

Valid until the market close on October 31, 2014

The S&P 500 closed September with a monthly loss of 1.55%. All three S&P 500 MAs and three of the five the Ivy Portfolio ETF MAs are signaling "Invested".

The Ivy Portfolio

The table below shows the current 10-month simple moving average (SMA) signal for each of the five ETFs featured in The Ivy Portfolio. I've also included a table of 12-month SMAs for the same ETFs for this popular alternative strategy.

For a facinating analysis of the Ivy Portfolio strategy, see this article by Adam Butler, Mike Philbrick and Rodrigo Gordillo:

more from Chart School

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.

To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Option Review

VIX Call Spreads Trade

The CBOE Vix Index topped 17.0 and the highest level since early-August on Monday morning amid declines in U.S. equities to start the trading week. The volatility index is off its earlier highs to trade 5.0% higher on the session at 15.65 as of 11:30 am ET. Options volume on the VIX is hovering near 360,000 contracts, or just more than 50% of the average daily reading of around 660,000 contracts. Calls are far more active than put options, as evidenced by the call/put ratio up above 4.2 in morning trading, perhaps as some traders position for volatility to stick around.

Large call spreads traded on the VIX today caught our attention as one big optio...

more from Caitlin


Sector Detector: Stocks fight off predictable weakness, but expect more downside

Courtesy of Sabrient Systems and Gradient Analytics

Yes, the market showed significant weakness last week for the first time in quite a while. In fact, the Dow Jones Industrial Average moved triple digits each day. But it was all quite predictable, as I suggested in last week's article, and certainly nothing to worry about. Now the market appears to be poised for a modest technical rebound, and longer term, U.S. equities should be in good shape for a year-end rally. However, I still believe more downside is in order before any new highs are challenged. Moreover, market breadth is important for a sustained bull run, so the challenge for investors will be to put together broader bullish conviction, including the small caps.

In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, re...

more from Sabrient


Swing trading portfolio - week of September 29th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.


This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

more from OpTrader

Market Shadows

Ebola vs. Us

Ebola vs. Us

By Ilene 

Ebola is spreading too quickly for Ebola-vaccine makers to conduct typical studies of safety and efficacy on experimental vaccines. Instead, vaccines will be tested for basic safety, but then deployed with protocols devised now in order to test for efficacy essentially on the field. Testing has to be expedited because the situation in West Africa gets worse every day while there are no approved vaccines or other treatments.

The chart below is from a paper in the New England Journal of Medicine showing estimates of the virus's trajectory projecting out to November 1, 2014. If current trends continue...

more from Paul

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

The latest issue of Stock World Weekly is now available. Please sign in with your PSW user name and password. Or simply take a free trial to try out our weekly newsletter. 


more from SWW


Last Chance! See The 'Google-Like' Trading Algorithm 'Live' TODAY

Traders and Investors,

RSVP NOW to attend a special presentation TODAY at Noon or 9:00 pm ET, where you’ll see a powerful trading algorithm that’s been tested and proven to return phenomenal results on a consistent basis. 

In fact, it has an 82% win rate…

And had you only traded the conservative alerts recommended by the algorithm since inception, you would have experienced portfolio gains of more than 200%!

Register NOW and secure your virtual seat for one of Today’s LIVE presentations.

When you register for the webinar, you’ll also get instant access to following trading videos:

  • Instant access to FOUR Quick-Start Expectancy...

more from Promotions

Digital Currencies

Making Sense of Bitcoin

Making Sense of Bitcoin

By James Black at International Man

Despite the various opinions on Bitcoin, there is no question as to its ultimate value: its ability to bypass government restrictions, including economic embargoes and capital controls, to transmit quasi-anonymous money to anyone anywhere.

Opinions differ as to what constitutes "money."

The English word "money" derives from the Latin word "moneta," which means to "mint." Historically, "money" was minted in the form of precious metals, most notably gold and silver. Minted metal was considered "money" because it possessed luster, was scarce, and had perceive...

more from Bitcoin


Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...

more from Pharmboy

FeedTheBull - Top Stock market and Finance Sites

About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

As Seen On:

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>